Increased monocyte cytokine production in association with systemic complications in acute pancreatitis

British Journal of Surgery

Volumn 83, Issue 7, 1996, Pages 919-923

  McKay, C J ^a   Gallagher, G ^a   Brooks, B ^a   Imrie, C W ^a   Baxter, J N ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OCTREOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; LUNG INSUFFICIENCY; MALE; MONOCYTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; PANCREATITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029978482     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830712     Document Type: Article

References (34)

1. Bradley EL, Hall JR, Lutz J, Hamner L, Lattouf O. Hemodynamic consequences of severe pancreatitis. Ann Surg 1983; 198: 130-3.
2. Beger HG, Bittner R, Buchler M, Hess W, Schmitz JE. Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986; 90: 74-9.
3. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105-12.
4. Tracey KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg 1990; 23: 21-56.
5. Frey CF, Wong HN, Hickman D, Pullos T. Toxicity of hemorrhagic ascitic fluid associated with hemorrhagic pancreatitis. Arch Surg 1982; 117: 401-4.
6. Ohlssen K, Tegner H. Experimental pancreatitis in the dog. Demonstration of trypsin in ascitic fluid, lymph and plasma. Scand J Gastroenterol 1973; 8: 129-33.
7. Amundsen E, Ofstad E, Hagen P-O. Experimental acute pancreatitis in dogs. I. Hypotensive effect induced by pancreatic exudate. Scand J Gastroenterol 1968; 3: 659-64.
8. Medical Research Council of the United Kingdom. Death from acute pancreatitis: MRC multicentre trial of glucagon and aprotinin. Lancet 1977; ii: 632-5.
9. Imrie CW, Benjamin IS, Ferguson JC et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65: 337-41.
10. Leese T, Holliday M, Heath D, Hall AW, Bell PRF. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987; 74: 907-11.
11. Leese T, Holliday M, Watkins M et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 1991; 73: 207-14.
12. Buchler M, Malfertheiner P, Uhl W et al. Gabexate mesilate in human acute pancreatitis. Gastroenterology 1993; 104: 1165-70.
13. Viedma JA, Perez-Mateo M, Dominguez JE, Carhallo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264-7.
14. Heath DI, Cruikshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-5.
15. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha. Cytokine 1991; 3: 12-16.
16. Exley AR, Leese T, Holliday MP, Swarm RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33: 1126-8.
17. McIntyre CA, Chapman K, Reeder S et al. Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants. Eur J Cancer 1992; 28: 58-63.
18. James K, van de Haan J, Lens S, Farmer K. Preliminary studies on the interaction of TNF alpha and IFN gamma with alpha 2-macroglobulin. Immunol Lett 1992; 32: 49-57.
19. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase 1 study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47: 2986-9.
20. Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 45-53.
21. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990; 77: 1260-4.
22. Pfueger E, Mueller EA, Anderer FA. Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods 1990; 129: 165-73.
23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
24. Cannon JG, Tompkins RG, Gelfand JA et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161: 79-84.
25. Calandra T, Baumgartner JD, Grau GE et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch JS Immunoglohin Study Group. J Infect Dis 1990; 161: 982-7.
26. Mulligan MS, Jones ML, Bolanowski MA et al. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993; 150: 5585-95.
27. Ventrucci M, Gionchetti P, Baraldini M, Boni P, Garulli L, Liguori L. Behaviour of serum interleukin-8 during the course of acute pancreatitis: comparison with serum interleukin-6 and C-reactive protein. Digestion 1993; 54: 314 (Abstract).
28. Schulz HU, Schmidt D, Kinz D, Meyer F, Lippert H. Altered immune function in acute pancreatitis: pathogenetic role and prognostic indicator. Digestion 1993; 54: 307-8 (Abstract).
29. Verma BK, Fogorasi M, Szabo G. Down-regulation of tumor necrosis factor alpha activity by acute ethanol treatment in human peripheral blood monocytes. J Clin Immunol 1993; 13: 8-22.
30. Baxter JN, Jenkins SA, Day DW, Shields R. Effects of a somatostatin analogue (SMS 201-995) on hepatic and splenic reticulo-endothelial function in the rat. Br J Surg 1985; 72: 1005-8.
31. Jenkins SA, Baxter JN, Day DW, Al-Sumidaie AM, Leinster SJ, Shields R. The effects of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxaemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klinische Wochenschrift 1986; 64(Suppl vii): 100-6.
32. Foulis AK, Murray WR, Galloway D et al. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982; 23: 656-61.
33. Kivilaakso E, Valtonen VV, Malkamaki M et al. Endotoxaemia and acute pancreatitis: correlation between the severity of the disease and the anti-enterobacterial common antigen antibody titre. Gut 1984; 25: 1065-70.
34. Banks RE, Evans SW, Alexander D, Van Leuvin F, Whicher JT, McMahon MJ. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut 1991; 32: 430-4.